Наименование |
Объем | Метод |
Кат.Номер |
GITR (M-20) |
200 мкг/мл | |
sc-7135 |
|
GITR (M-20) P |
100 µg/0.5 ml | |
sc-7135 P |
|
GITR (N-14) |
200 мкг/мл | |
sc-5759 |
|
GITR (N-14) P |
100 µg/0.5 ml | |
sc-5759 P |
|
GITR (YGITR860.14.7) |
200 мкг/мл | |
sc-53843 |
|
GITR siRNA (h) |
10 µM | |
sc-43806 |
|
GL50 (h)-PR |
10 µM, 20 µl | |
sc-42768-PR |
|
GL50 (m)-PR |
10 µM, 20 µl | |
sc-42769-PR |
|
Glycophorin A (NaM10-6G4) |
200 мкг/мл | |
sc-51737 |
|
Glycophorin A (11E4B7.6) |
100 мкг/мл | |
sc-59180 |
|
Glycophorin A (A63-B/C2) |
100 мкг/мл | |
sc-65281 |
|
Glycophorin A (C-20) |
200 мкг/мл | |
sc-19452 |
|
Glycophorin A (C-20) P |
100 µg/0.5 ml | |
sc-19452 P |
|
Glycophorin A (E-18) |
200 мкг/мл | |
sc-19451 |
|
Glycophorin A (E-18) P |
100 µg/0.5 ml | |
sc-19451 P |
|
Glycophorin A (E4) |
200 мкг/мл | |
sc-59181 |
|
Glycophorin A (h)-PR |
10 µM, 20 µl | |
sc-42882-PR |
|
Glycophorin A (H-60) |
200 мкг/мл | |
sc-20628 |
|
Glycophorin A (I-20) |
200 мкг/мл | |
sc-19453 |
|
Glycophorin A (I-20) P |
100 µg/0.5 ml | |
sc-19453 P |
|
Glycophorin A (JC159) |
200 мкг/мл | |
sc-53295 |
|
Glycophorin A (m) -PR |
10 µM, 20 µl | |
sc-44730-PR |
|
Glycophorin A (NaM10-6G4) FITC |
100 tests in 2 ml | |
sc-51737 FITC |
|
Glycophorin A (R10) |
200 мкг/мл | |
sc-53905 |
|
Glycophorin A (YTH89.1) |
200 мкг/мл | |
sc-59182 |
|
Glycophorin A siRNA (h) |
10 µM | |
sc-42882 |
|
Glycophorin A siRNA (m) |
10 µM | |
sc-44730 |
|
Glycophorin A/B (HIR2) |
100 µg/ml | |
sc-51603 |
|
Glycophorin A/B (HIR2) FITC |
100 tests in 2 ml | |
sc-51603 FITC |
|
Glycophorin A/B (HIR2) PE |
100 tests in 2ml | |
sc-51603 PE |
|
Glycophorin B (E-20) |
200 мкг/мл | |
sc-19456 |
|
Glycophorin B (E-20) P |
100 µg/0.5 ml | |
sc-19456 P |
|
Glycophorin B (h)-PR |
10 µM, 20 µl | |
sc-42883-PR |
|
Glycophorin B (H-46) |
200 мкг/мл | |
sc-33561 |
|
Glycophorin B siRNA (h) |
10 µM | |
sc-42883 |
|
Glycophorin C (BGRL 100) |
200 мкг/мл | |
sc-59184 |
|
Glycophorin C (E5) |
200 мкг/мл | |
sc-59185 |
|
Glycophorin C (h)-PR |
10 µM, 20 µl | |
sc-42884-PR |
|
Glycophorin C (Ret40f) |
100 мкг/мл | |
sc-59186 |
|
Glycophorin C siRNA (h) |
10 µM | |
sc-42884 |
|
Glycophorin C/D (D-20) |
200 мкг/мл | |
sc-23809 |
|
Glycophorin C/D (D-20) P |
100 µg/0.5 ml | |
sc-23809 P |
|
Glycophorin C/D (H-85) |
200 мкг/мл | |
sc-20629 |
|
Glycophorin C/D (T-17) |
200 мкг/мл | |
sc-19458 |
|
Glycophorin C/D (T-17) P |
100 µg/0.5 ml | |
sc-19458 P |
|
GP49 (A-20) |
200 мкг/мл | |
sc-17078 |
|
GP49 (A-20) P |
100 µg/0.5 ml | |
sc-17078 P |
|
GP49 (H1.1) |
200 мкг/мл | |
sc-53584 |
|
GP49 (H1.1) FITC |
100 tests in 2 ml | |
sc-53584 FITC |
|
GP49 (H1.1) PE |
100 tests in 2ml | |
sc-53584 PE |
|
GP49 (N-20) |
200 мкг/мл | |
sc-17076 |
|
GP49 (N-20) P |
100 µg/0.5 ml | |
sc-17076 P |
|
GP49A (m)-PR |
10 µM, 20 µl | |
sc-42885-PR |
|
GP49A siRNA (m) |
10 µM | |
sc-42885 |
|
GP49B (L-18) |
200 мкг/мл | |
sc-17075 |
|
GP49B (L-18) P |
100 µg/0.5 ml | |
sc-17075 P |
|
GP49B (m)-PR |
10 µM, 20 µl | |
sc-42886-PR |
|
GP49B siRNA (m) |
10 µM | |
sc-42886 |
|
GPVI (201-339) |
10 µg/0.1 ml | |
sc-4529 WB |
|
GPVI (h)-PR |
10 µM, 20 µl | |
sc-43813-PR |
|
GPVI (H-139) |
200 мкг/мл | |
sc-20149 |
|
GPVI (N-20) |
200 мкг/мл | |
sc-23551 |
|
GPVI (N-20) P |
100 µg/0.5 ml | |
sc-23551 P |
|
GPVI siRNA (h) |
10 µM | |
sc-43813 |
|
GPVI-2 (h)-PR |
10 µM, 20 µl | |
sc-42780-PR |
|
GPVI-2 siRNA (h) |
10 µM | |
sc-42780 |
|
Granulocyte Marker (MOM/3F12/F2) |
100 мкг/мл | |
sc-59188 |
|
Granulocytes (HIS48) |
200 мкг/мл | |
sc-19613 |
|
Granulocytes Subset (HIS48) FITC |
100 tests in 2 ml | |
sc-19613 FITC |
|
Granulocytes Subset (HIS48) PE |
100 tests in 2ml | |
sc-19613 PE |
|
granulysin (C-13) |
200 мкг/мл | |
sc-31316 |
|
granulysin (C-13) P |
100 µg/0.5 ml | |
sc-31316 P |
|
granulysin (h)-PR |
10 µM, 20 µl | |
sc-42887-PR |
|
granulysin (H-130) |
200 мкг/мл | |
sc-28821 |
|
granulysin (N-20) |
200 мкг/мл | |
sc-16968 |
|
granulysin (N-20) P |
100 µg/0.5 ml | |
sc-16968 P |
|
granulysin siRNA (h) |
10 µM | |
sc-42887 |
|
Growth Cone Marker (2G13) (маркер конуса роста) |
100 мкг/мл | |
sc-59189 |
|
GTAM1 Marker (B48.1) |
500 µl supernatant | |
sc-59190 |
|
GTAM11 Marker (B43.11) |
100 мкг/мл | |
sc-59191 |
|
GTAM12 Marker (B43.12) |
100 мкг/мл | |
sc-59192 |
|
GTAM2 Marker (B43.2) |
500 µl supernatant | |
sc-59193 |
|
GTAM5 Marker (B43.5) |
500 µl supernatant | |
sc-59194 |
|
GTAM8 Marker (B43.8) |
500 µl supernatant | |
sc-59195 |
|
H2-Db (27-11-13) |
100 µg/ml | |
sc-52540 |
|
H2-Db (27-11-13) FITC |
100 tests in 2 ml | |
sc-52540 FITC |
|
H2-Db (28-14-8) |
100 µg/ml | |
sc-52541 |
|
H2-Db (28-14-8) FITC |
100 tests in 2 ml | |
sc-52541 FITC |
|
H2-Db (28-14-8) PE |
100 tests in 2ml | |
sc-52541 PE |
|
H2-Dd (34-5-8S) |
100 µg/ml | |
sc-52542 |
|
H2-Dd (34-5-8S) FITC |
100 tests in 2 ml | |
sc-52542 FITC |
|
H2-Dd (34-5-8S) PE |
100 tests in 2ml | |
sc-52542 PE |
|
H2-Dk (15-5-5) |
100 µg/ml | |
sc-52543 |
|
H2-Dk (15-5-5) FITC |
100 tests in 2 ml | |
sc-52543 FITC |
|
H2-Dk (15-5-5) PE |
100 tests in 2ml | |
sc-52543 PE |
|
H2-I/A (NIMR-4) |
200 мкг/мл | |
sc-52548 |
|
H2-I/A (NIMR-4) FITC |
100 tests in 2 ml | |
sc-52548 FITC |
|
H2-I/A (NIMR-4) PE |
100 tests in 2ml | |
sc-52548 PE |
|
H2-I/Ab (25-5-16S) |
100 мкг/мл | |
sc-59196 |
|
H2-I/Ab (28-16-8S) |
100 µg/ml | |
sc-59197 |
|
H2-I/Abβ (25-9-3) |
100 µg/ml | |
sc-52537 |
|
H2-I/Abβ (25-9-3) FITC |
100 tests in 2 ml | |
sc-52537 FITC |
|
H2-I/Abβ (25-9-3) PE |
100 tests in 2ml | |
sc-52537 PE |
|
H2-I/Adβ (34-5-3) |
100 µg/ml | |
sc-52538 |
|
H2-I/Eκ (14-4-4S) |
100 µg/ml | |
sc-52546 |
|
H2-I/Eκ (14-4-4S) FITC |
100 tests in 2 ml | |
sc-52546 FITC |
|
H2-I/Eκ (14-4-4S) PE |
100 tests in 2ml | |
sc-52546 PE |
|
H2-I/Eκ (17-3-3) |
100 µg/ml | |
sc-52547 |
|
H2-I/Eκ (17-3-3) FITC |
100 tests in 2 ml | |
sc-52547 FITC |
|
H2-I/Eκ (17-3-3) PE |
100 tests in 2ml | |
sc-52547 PE |
|
H2-I-A/I-E (M5/114) |
200 мкг/мл | |
sc-23940 |
|
H2-I-A/I-E (M5/114) FITC |
100 tests in 2 ml | |
sc-23940 FITC |
|
H2-I-A/I-E (M5/114) PE |
100 tests in 2ml | |
sc-23940 PE |
|
H2-Kd (SF1-1.1) |
200 мкг/мл | |
sc-53852 |
|
H2-Kd/Dd (34-1-2S) (молекула основеного комплекса гистосовместимости) |
100 мкг/мл | |
sc-52549 |
|
H2-Kd/Dd (34-1-2S) FITC (молекула основеного комплекса гистосовместимости) |
100 тестов в 2 мл | |
sc-52549 FITC |
|
H2-Kd/Dd (34-1-2S) PE (молекула основеного комплекса гистосовместимости) |
100 тестов в 2 мл | |
sc-52549 PE |
|
H2-Kk (16-3.22) |
100 µg/ml | |
sc-52550 |
|
H2-Kk (16-3.22) FITC |
100 tests in 2 ml | |
sc-52550 FITC |
|
H2-Kk (16-3.22) PE |
100 tests in 2ml | |
sc-52550 PE |
|
H2-Kk (36-7-5) |
100 µg/ml | |
sc-52551 |
|
H2-Kk (36-7-5) FITC |
100 tests in 2 ml | |
sc-52551 FITC |
|
H2-Kk (36-7-5) PE |
100 tests in 2ml | |
sc-52551 PE |
|
H2-Kk (AF3-12.1) |
200 мкг/мл | |
sc-53851 |
|
H2-Kk (B1B8.C2-Ky99) |
100 µg/ml | |
sc-59201 |
|
H60 (C-20) |
200 мкг/мл | |
sc-20330 |
|
H60 (C-20) P |
100 µg/0.5 ml | |
sc-20330 P |
|
H60 (m)-PR |
10 µM, 20 µl | |
sc-42936-PR |
|
H60 siRNA (m) |
10 µM | |
sc-42936 |
|
Hairy Cell Leukemia Marker (DBA.44) |
100 мкг/мл | |
sc-59202 |
|
Hephaestin (h)-PR |
10 µM, 20 µl | |
sc-60780-PR |
|
Hephaestin (L-20) |
200 мкг/мл | |
sc-49969 |
|
Hephaestin (L-20) P |
100 µg/0.5 ml | |
sc-49969 P |
|
Hephaestin (m)-PR |
10 µM, 20 µl | |
sc-60781-PR |
|
Hephaestin (N-20) |
200 мкг/мл | |
sc-49970 |
|
Hephaestin (N-20) P |
100 µg/0.5 ml | |
sc-49970 P |
|
Hephaestin siRNA (h) |
10 µM | |
sc-60780 |
|
Hephaestin siRNA (m) |
10 µM | |
sc-60781 |
|
HFE (h)-PR |
10 µM, 20 µl | |
sc-43832-PR |
|
HFE (K-16) |
200 мкг/мл | |
sc-18807 |
|
HFE (K-16) P |
100 µg/0.5 ml | |
sc-18807 P |
|
HFE (T-15) |
200 мкг/мл | |
sc-18810 |
|
HFE (T-15) P |
100 µg/0.5 ml | |
sc-18810 P |
|
HFE (V-14) |
200 мкг/мл | |
sc-18806 |
|
HFE (V-14) P |
100 µg/0.5 ml | |
sc-18806 P |
|
HFE siRNA (h) |
10 µM | |
sc-43832 |
|
HL60 Antigen (IPO-M6) |
200 мкг/мл | |
sc-59203 |
|
HLA class I (B-D11) |
1.25 ml supernatant | |
sc-65319 |
|
HLA class I (MEM-123) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51671 |
|
HLA class I (MEM-123) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51671 FITC |
|
HLA class I (MEM-123) PE (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51671 PE |
|
HLA class I (MEM-147) |
100 µg/ml | |
sc-51672 |
|
HLA class I (MEM-147) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51672 FITC |
|
HLA class I (MEM-147) PE |
100 tests in 2ml | |
sc-51672 PE |
|
HLA class I (MEM-81) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51673 |
|
HLA DR7/DRβ (TAL 13.1) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53303 |
|
HLA-A (A-18) |
200 мкг/мл | |
sc-23446 |
|
HLA-A (A-18) P |
100 µg/0.5 ml | |
sc-23446 P |
|
HLA-A (F-18) |
200 мкг/мл | |
sc-23445 |
|
HLA-A (F-18) P |
100 µg/0.5 ml | |
sc-23445 P |
|
HLA-A (h)-PR |
10 µM, 20 µl | |
sc-42908-PR |
|
HLA-A (N-20) |
200 мкг/мл | |
sc-17653 |
|
HLA-A (N-20) P |
100 µg/0.5 ml | |
sc-17653 P |
|
HLA-A siRNA (h) |
10 µM | |
sc-42908 |
|
HLA-A/B/C (3F10) |
100 µg/ml | |
sc-65288 |
|
HLA-A/B/C (H-300) |
200 мкг/мл | |
sc-30204 |
|
HLA-A/B/C (ICO-53) |
100 µg/ml | |
sc-52422 |
|
HLA-A/B/C (ICO-53) FITC |
100 tests in 2 ml | |
sc-52422 FITC |
|
HLA-A/B/C (LY5.1) |
100 µg/ml | |
sc-52810 |
|
HLA-A2 (BB7.2) FITC |
100 tests in 2 ml | |
sc-32236 FITC |
|
HLA-A2 (BB7.2) PE |
100 tests in 2ml | |
sc-32236 PE |
|
HLA-B (N-20) |
200 мкг/мл | |
sc-19440 |
|
HLA-B (N-20) P |
100 µg/0.5 ml | |
sc-19440 P |
|
HLA-B/C (D-20) |
200 мкг/мл | |
sc-19439 |
|
HLA-B/C (D-20) P |
100 µg/0.5 ml | |
sc-19439 P |
|
HLA-B/C (N-20) |
200 мкг/мл | |
sc-19437 |
|
HLA-B/C (N-20) P |
100 µg/0.5 ml | |
sc-19437 P |
|
HLA-B27 (EP-4) |
100 µg/ml | |
sc-59233 |
|
HLA-B7 (BB7.1) |
200 мкг/мл | |
sc-53304 |
|
HLA-C (Q-18) |
200 мкг/мл | |
sc-19438 |
|
HLA-C (Q-18) P |
100 µg/0.5 ml | |
sc-19438 P |
|
HLA-D (CVS20) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-59240 |
|
HLA-D (TAL 5.1) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53306 |
|
HLA-D/DR/DQ (35) |
200 мкг/мл | |
sc-53305 |
|
HLA-DM (MaP.DM1) |
200 мкг/мл | |
sc-32248 |
|
HLA-DM (MaP.DM1) FITC |
100 tests in 2 ml | |
sc-32248 FITC |
|
HLA-DM (MaP.DM1) PE |
100 tests in 2ml | |
sc-32248 PE |
|
HLA-DM (TAL 18.1) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53307 |
|
HLA-DMα (E-20) |
200 мкг/мл | |
sc-14532 |
|
HLA-DMα (E-20) P |
100 µg/0.5 ml | |
sc-14532 P |
|
HLA-DMα (h)-PR |
10 µM, 20 µl | |
sc-42909-PR |
|
HLA-DMα (I-19) |
200 мкг/мл | |
sc-14536 |
|
HLA-DMα (I-19) P |
100 µg/0.5 ml | |
sc-14536 P |
|
HLA-DMα (m)-PR |
10 µM, 20 µl | |
sc-42910-PR |
|
HLA-DMα (M-15) |
200 мкг/мл | |
sc-14537 |
|
HLA-DMα (M-15) P |
100 µg/0.5 ml | |
sc-14537 P |
|
HLA-DMα siRNA (h) |
10 µM | |
sc-42909 |
|
HLA-DMα siRNA (m) |
10 µM | |
sc-42910 |
|
HLA-DMβ (h)-PR |
10 µM, 20 µl | |
sc-42911-PR |
|
HLA-DMβ (K-20) |
200 мкг/мл | |
sc-14540 |
|
HLA-DMβ (K-20) P |
100 µg/0.5 ml | |
sc-14540 P |
|
HLA-DMβ (L-14) |
200 мкг/мл | |
sc-14539 |
|
HLA-DMβ (L-14) P |
100 µg/0.5 ml | |
sc-14539 P |
|
HLA-DMβ siRNA (h) |
10 µM | |
sc-42911 |
|
HLA-DMβ siRNA (m) |
10 µM | |
sc-42912 |
|
HLA-DOβ (E-17) |
200 мкг/мл | |
sc-14546 |
|
HLA-DOβ (E-17) P |
100 µg/0.5 ml | |
sc-14546 P |
|
HLA-DOβ (h) -PR |
10 µM, 20 µl | |
sc-42913-PR |
|
HLA-DOβ (m) -PR |
10 µM, 20 µl | |
sc-42914-PR |
|
HLA-DOβ (M-15) |
200 мкг/мл | |
sc-14547 |
|
HLA-DOβ (M-15) P |
100 µg/0.5 ml | |
sc-14547 P |
|
HLA-DOβ (V-16) |
200 мкг/мл | |
sc-14543 |
|
HLA-DOβ (V-16) P |
100 µg/0.5 ml | |
sc-14543 P |
|
HLA-DOβ siRNA (h) |
10 µM | |
sc-42913 |
|
HLA-DOβ siRNA (m) |
10 µM | |
sc-42914 |
|
HLA-DP (BRAFB6) |
200 мкг/мл | |
sc-33719 |
|
HLA-DP (BRAFB6) FITC |
100 tests in 2 ml | |
sc-33719 FITC |
|
HLA-DP (BRAFB6) PE |
100 tests in 2ml | |
sc-33719 PE |
|
HLA-DP (DP 11.1) |
200 мкг/мл | |
sc-53308 |
|
HLA-DP (E-20) |
200 мкг/мл | |
sc-19435 |
|
HLA-DP (E-20) P |
100 µg/0.5 ml | |
sc-19435 P |
|
HLA-DP (TAL 3C3) |
200 мкг/мл | |
sc-53309 |
|
HLA-DP β1 (h)-PR |
10 µM, 20 µl | |
sc-42915-PR |
|
HLA-DP β1 (m)-PR |
10 µM, 20 µl | |
sc-42916-PR |
|
HLA-DP β1 siRNA (h) |
10 µM | |
sc-42915 |
|
HLA-DP β1 siRNA (m) |
10 µM | |
sc-42916 |
|
HLA-DQ (B-K27) |
100 µg/ml | |
sc-65320 |
|
HLA-DQ (B-K27) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-65320 FITC |
|
HLA-DQ (B-K27) PE (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-65320 PE |
|
HLA-DQ1/3 (HL-37) |
100 µg/ml | |
sc-51615 |
|
HLA-DQ1/3 (HL-37) FITC |
100 tests in 2 ml | |
sc-51615 FITC |
|
HLA-DQ1/3 (HL-37) PE |
100 tests in 2ml | |
sc-51615 PE |
|
HLA-DQ3 (2HB6) |
200 мкг/мл | |
sc-53310 |
|
HLA-DQ3/DQ4/DR4 (TAL 12.1) |
200 мкг/мл | |
sc-53311 |
|
HLA-DQA1 (h)-PR |
10 µM, 20 µl | |
sc-42917-PR |
|
HLA-DQA1 (TAL 4.1) |
200 мкг/мл | |
sc-53312 |
|
HLA-DQA1 siRNA (h) |
10 µM | |
sc-42917 |
|
HLA-DQA1/2 (N-20) |
200 мкг/мл | |
sc-17960 |
|
HLA-DQA1/2 (N-20) P |
100 µg/0.5 ml | |
sc-17960 P |
|
HLA-DQB1 (Genox 3.53) |
200 мкг/мл | |
sc-53313 |
|
HLA-DQB1 (h)-PR |
10 µM, 20 µl | |
sc-42918-PR |
|
HLA-DQB1 (IIB3) |
200 мкг/мл | |
sc-59247 |
|
HLA-DQB1 (N-18) |
200 мкг/мл | |
sc-17963 |
|
HLA-DQB1 (N-18) P |
100 µg/0.5 ml | |
sc-17963 P |
|
HLA-DQB1 siRNA (h) |
10 µM | |
sc-42918 |
|
HLA-DR (2.06) |
200 мкг/мл | |
sc-53517 |
|
HLA-DR (B-F1) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-59249 |
|
HLA-DR (Bra20) |
200 мкг/мл | |
sc-33720 |
|
HLA-DR (Bra20) FITC |
100 tests in 2 ml | |
sc-33720 FITC |
|
HLA-DR (Bra20) PE |
100 tests in 2ml | |
sc-33720 PE |
|
HLA-DR (Bra22) |
200 мкг/мл | |
sc-33718 |
|
HLA-DR (Bra22) FITC |
100 tests in 2 ml | |
sc-33718 FITC |
|
HLA-DR (Bra22) PE |
100 tests in 2ml | |
sc-33718 PE |
|
HLA-DR (Bra30) |
200 мкг/мл | |
sc-33717 |
|
HLA-DR (Bra30) FITC |
100 tests in 2 ml | |
sc-33717 FITC |
|
HLA-DR (Bra30) PE |
100 tests in 2ml | |
sc-33717 PE |
|
HLA-DR (h)-PR |
10 µM, 20 µl | |
sc-42919-PR |
|
HLA-DR (HL-39) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51619 |
|
HLA-DR (HL-39) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51619 FITC |
|
HLA-DR (HL-39) PE (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51619 PE |
|
HLA-DR (ICO-1) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-52423 |
|
HLA-DR (ICO-1) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-52423 FITC |
|
HLA-DR (L243) |
200 мкг/мл | |
sc-18875 |
|
HLA-DR (L243) APC |
100 tests in 2ml | |
sc-18875 APC |
|
HLA-DR (L243) FITC |
100 tests in 2 ml | |
sc-18875 FITC |
|
HLA-DR (L243) PE |
100 tests in 2ml | |
sc-18875 PE |
|
HLA-DR (LDR) |
100 мкг/мл | |
sc-51947 |
|
HLA-DR (LHM 4) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53315 |
|
HLA-DR (LN3) |
200 мкг/мл | |
sc-59252 |
|
HLA-DR (MEM-267) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51620 |
|
HLA-DR (MEM-267) FITC (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51620 FITC |
|
HLA-DR (MEM-267) PE (лейкоцитарный антиген человека) |
100 тестов в 2 мл | |
sc-51620 PE |
|
HLA-DR (TAL 15.1) |
200 мкг/мл | |
sc-53317 |
|
HLA-DR (TAL 16.1) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53318 |
|
HLA-DR (TAL 1B5) |
200 мкг/мл | |
sc-53319 |
|
HLA-DR (TAL 8.1) (лейкоцитарный антиген человека) |
200 мкг/мл | |
sc-53320 |
|
HLA-DR (YE2/36HLK) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-59257 |
|
HLA-DR siRNA (h) |
10 µM | |
sc-42919 |
|
HLA-DR/DP (HL-38) |
100 µg/ml | |
sc-51616 |
|
HLA-DR/DP (HL-38) FITC |
100 tests in 2 ml | |
sc-51616 FITC |
|
HLA-DR/DP (HL-38) PE |
100 tests in 2ml | |
sc-51616 PE |
|
HLA-DR/DP (HL-40) |
100 µg/ml | |
sc-51617 |
|
HLA-DR/DP (HL-40) FITC |
100 tests in 2 ml | |
sc-51617 FITC |
|
HLA-DR/DP (HL-40) PE |
100 tests in 2ml | |
sc-51617 PE |
|
HLA-DR/DP (MEM-136) |
100 µg/ml | |
sc-51618 |
|
HLA-DR/DP (MEM-136) FITC |
100 tests in 2 ml | |
sc-51618 FITC |
|
HLA-DR/DP (MEM-136) PE |
100 tests in 2ml | |
sc-51618 PE |
|
HLA-DR/DP/DQ/DX (CR3/43) |
200 мкг/мл | |
sc-53302 |
|
HLA-DRα (h)-PR |
10 µM, 20 µl | |
sc-37113-PR |
|
HLA-DRα (m)-PR |
10 µM, 20 µl | |
sc-37114-PR |
|
HLA-DRα siRNA (h) |
10 µM | |
sc-37113 |
|
HLA-DRα siRNA (m) |
10 µM | |
sc-37114 |
|
HLA-DRα (DA6.147) |
200 мкг/мл | |
sc-53499 |
|
HLA-DRα (F-19) |
200 мкг/мл | |
sc-14550 |
|
HLA-DRα (F-19) P |
100 µg/0.5 ml | |
sc-14550 P |
|
HLA-DRα (FL-254) |
200 мкг/мл | |
sc-25614 |
|
HLA-DRβ (DA2) |
200 мкг/мл | |
sc-53314 |
|
HLA-DRβ (TAL 14.1) |
200 мкг/мл | |
sc-53316 |
|
HLA-DRβ (TDR 31.1) |
200 мкг/мл | |
sc-53321 |
|
HLA-DRβ5 (4D12) |
200 мкг/мл | |
sc-53889 |
|
HLA-E (MEM-E/02) |
100 µg/ml | |
sc-51621 |
|
HLA-E (MEM-E/06) |
100 µg/ml | |
sc-51622 |
|
HLA-E (MEM-E/07) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51623 |
|
HLA-E (MEM-E/08) |
100 µg/ml | |
sc-51624 |
|
HLA-G (4H84) |
200 мкг/мл | |
sc-21799 |
|
HLA-G (87G) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-59262 |
|
HLA-G (9-1F10) |
200 мкг/мл | |
sc-53825 |
|
HLA-G (A-20) |
200 мкг/мл | |
sc-17958 |
|
HLA-G (A-20) P |
100 µg/0.5 ml | |
sc-17958 P |
|
HLA-G (D-20) |
200 мкг/мл | |
sc-17959 |
|
HLA-G (D-20) P |
100 µg/0.5 ml | |
sc-17959 P |
|
HLA-G (h)-PR |
10 µM, 20 µl | |
sc-42920-PR |
|
HLA-G (m)-PR |
10 µM, 20 µl | |
sc-42921-PR |
|
HLA-G (MEM-G/1) |
100 µg/ml | |
sc-51674 |
|
HLA-G (MEM-G/11) (лейкоцитарный антиген человека) |
100 мкг/мл | |
sc-51675 |
|
HLA-G (MEM-G/2) |
100 µg/ml | |
sc-51676 |
|
HLA-G (MEM-G/4) |
100 мкг/мл | |
sc-51677 |
|
HLA-G (MEM-G/9) |
100 µg/ml | |
sc-51678 |
|
HLA-G siRNA (h) |
10 µM | |
sc-42920 |
|
HLA-G siRNA (m) |
10 µM | |
sc-42921 |
|
Hu-CD103/CD22/ CD20 |
50 tests | |
sc-3930 |
|
Hu-CD103/CD22/ CD20 control |
50 tests | |
sc-3930 CON |
|
Hu-CD14/CD64 |
50 tests | |
sc-3935 |
|
Hu-CD14/CD64 control |
50 tests | |
sc-3935 CON |
|
Hu-CD15/CD117 |
50 tests | |
sc-3936 |
|
Hu-CD15/CD117 control |
50 tests | |
sc-3936 CON |
|
Hu-CD15/CD34 |
50 tests | |
sc-3937 |
|
Hu-CD15/CD34 control |
50 tests | |
sc-3937 CON |
|
Hu-CD19/CD69/CD45 |
50 tests | |
sc-3607 |
|
Hu-CD19/CD69/CD45 control |
50 tests | |
sc-3607 CON |
|
Hu-CD2/CD7/CD3 |
50 tests | |
sc-2938 |
|
Hu-CD2/CD7/CD3 control |
50 tests | |
sc-2938 CON |
|
Hu-CD3/CD16+CD56 |
50 tests | |
sc-3951 |
|
Hu-CD3/CD16+CD56 control |
50 tests | |
sc-3951 CON |
|
Hu-CD3/CD16+CD56/ CD45 |
50 tests | |
sc-2911 |
|
Hu-CD3/CD16+CD56/ CD45 control |
50 tests | |
sc-2911 CON |
|
Hu-CD3/CD16+CD56/ CD45/CD19 |
50 tests | |
sc-2919 |
|
Hu-CD3/CD16+CD56/ CD45/CD19 control |
50 tests | |
sc-2919 CON |
|
Hu-CD3/CD19 |
50 tests | |
sc-3952 |
|
Hu-CD3/CD19 control |
50 tests | |
sc-3952 CON |
|
Hu-CD3/CD19/CD45 |
50 tests | |
sc-2912 |
|
Hu-CD3/CD19/CD45 control |
50 tests | |
sc-2912 CON |
|
Hu-CD3/CD4 |
50 tests | |
sc-3949 |
|
Hu-CD3/CD4 control |
50 tests | |
sc-3949 CON |
|
Hu-CD3/CD4/CD45 |
50 tests | |
sc-2913 |
|
Hu-CD3/CD4/CD45 control |
50 tests | |
sc-2913 CON |
|
Hu-CD3/CD8 |
50 tests | |
sc-3950 |
|
Hu-CD3/CD8 control |
50 tests | |
sc-3950 CON |
|
Hu-CD3/CD8/CD45 |
50 tests | |
sc-2936 |
|
Hu-CD3/CD8/CD45 control |
50 tests | |
sc-2936 CON |
|
Hu-CD3/CD8/CD45/ CD4 |
50 tests | |
sc-2920 |
|
Hu-CD3/CD8/CD45/ CD4 control |
50 tests | |
sc-2920 CON |
|
Hu-CD3/HLA-DR |
50 tests | |
sc-3953 |
|
Hu-CD3/HLA-DR control |
50 tests | |
sc-3953 CON |
|
Hu-CD38/CD56/CD19 |
50 tests | |
sc-3929 |
|
Hu-CD38/CD56/CD19 control |
50 tests | |
sc-3929 CON |
|
Hu-CD4/CD25/CD3 |
50 tests | |
sc-2939 |
|
Hu-CD4/CD25/CD3 control |
50 tests | |
sc-2939 CON |
|
Hu-CD4/CD38/CD3/ HLA-DR |
50 tests | |
sc-2921 |
|
Hu-CD4/CD38/CD3/ HLA-DR control |
50 tests | |
sc-2921 CON |
|
Hu-CD4/CD62L |
50 tests | |
sc-3955 |
|
Hu-CD4/CD62L control |
50 tests | |
sc-3955 CON |
|
Hu-CD4/CD69/CD3 |
50 tests | |
sc-3605 |
|
Hu-CD4/CD69/CD3 control |
50 tests | |
sc-3605 CON |
|
Hu-CD4/CD8 |
50 tests | |
sc-3954 |
|
Hu-CD4/CD8 control |
50 tests | |
sc-3954 CON |
|
Hu-CD4/CD8/CD3 |
50 tests | |
sc-2937 |
|
Hu-CD4/CD8/CD3 control |
50 tests | |
sc-2937 CON |
|
Hu-CD45/CD14 |
50 tests | |
sc-3943 |
|
Hu-CD45/CD14 control |
50 tests | |
sc-3943 CON |
|
Hu-CD45RA/CD45RO/ CD3/CD4 |
50 tests | |
sc-2946 |
|
Hu-CD45RA/CD45RO/ CD3/CD4 control |
50 tests | |
sc-2946 CON |
|
Hu-CD45RA/CD45RO/ CD3/CD8 |
50 tests | |
sc-2947 |
|
Hu-CD45RA/CD45RO/ CD3/CD8 control |
50 tests | |
sc-2947 CON |
|
Hu-CD45RA/CD62L/ CD3/CD4 |
50 tests | |
sc-2948 |
|
Hu-CD45RA/CD62L/ CD3/CD4 control |
50 tests | |
sc-2948 CON |
|
Hu-CD45RA/CD62L/ CD3/CD8 |
50 tests | |
sc-2909 |
|
Hu-CD45RA/CD62L/ CD3/CD8 control |
50 tests | |
sc-2909 CON |
|
Hu-CD5/CD10/CD19 |
50 tests | |
sc-3928 |
|
Hu-CD5/CD10/CD19 control |
50 tests | |
sc-3928 CON |
|
Hu-CD5/CD19 |
50 tests | |
sc-3956 |
|
Hu-CD5/CD19 control |
50 tests | |
sc-3956 CON |
|
Hu-CD56/CD69/CD4 |
50 tests | |
sc-3608 |
|
Hu-CD56/CD69/CD4 control |
50 tests | |
sc-3608 CON |
|
Hu-CD57/CD16/CD3 |
50 tests | |
sc-3927 |
|
Hu-CD57/CD16/CD3 control |
50 tests | |
sc-3927 CON |
|
Hu-CD57/CD8 |
50 tests | |
sc-3960 |
|
Hu-CD57/CD8 control |
50 tests | |
sc-3960 CON |
|
Hu-CD64/CD45 |
50 tests | |
sc-3611 |
|
Hu-CD64/CD45 control |
50 tests | |
sc-3611 CON |
|
Hu-CD69/CD3 |
50 tests | |
sc-3612 |
|
Hu-CD69/CD3 control |
50 tests | |
sc-3612 CON |
|
Hu-CD7/CD33 |
50 tests | |
sc-3938 |
|
Hu-CD7/CD33 control |
50 tests | |
sc-3938 CON |
|
Hu-CD8/CD28 |
50 tests | |
sc-3957 |
|
Hu-CD8/CD28 control |
50 tests | |
sc-3957 CON |
|
Hu-CD8/CD38 |
50 tests | |
sc-3958 |
|
Hu-CD8/CD38 control |
50 tests | |
sc-3958 CON |
|
Hu-CD8/CD38/CD3 |
50 tests | |
sc-3604 |
|
Hu-CD8/CD38/CD3 control |
50 tests | |
sc-3604 CON |
|
Hu-CD8/CD38/CD3/ HLA-DR |
50 tests | |
sc-2910 |
|
Hu-CD8/CD38/CD3/ HLA-DR control |
50 tests | |
sc-2910 CON |
|
Hu-CD8/CD56/CD3 |
50 tests | |
sc-2940 |
|
Hu-CD8/CD56/CD3 control |
50 tests | |
sc-2940 CON |
|
Hu-CD8/CD69/CD3 |
50 tests | |
sc-3606 |
|
Hu-CD8/CD69/CD3 control |
50 tests | |
sc-3606 CON |
|
Hu-CD8/HLA-DR |
50 tests | |
sc-3959 |
|
Hu-CD8/HLA-DR control |
50 tests | |
sc-3959 CON |
|
Hu-HLA-DR/CD13 |
50 tests | |
sc-3939 |
|
Hu-HLA-DR/CD13 control |
50 tests | |
sc-3939 CON |
|
Hu-HLA-DR/CD34 |
50 tests | |
sc-3942 |
|
Hu-HLA-DR/CD34 control |
50 tests | |
sc-3942 CON |
|
Hu-IFN- γ /IL-4 control |
50 тестов | |
sc-3613 CON |
|
Hu-IFN-γ/CD69/CD4 |
50 tests | |
sc-3609 |
|
Hu-IFN-γ/CD69/CD4 control |
50 tests | |
sc-3609 CON |
|
Hu-IFN-γ/CD69/CD8/ CD3 |
50 tests | |
sc-3603 |
|
Hu-IFN-γ/CD69/CD8/ CD3 control |
50 tests | |
sc-3603 CON |
|
Hu-IFN-γ/IL-4 |
50 tests | |
sc-3613 |
|
human IgM (MHM-88) |
100 мкг/мл | |
sc-53696 |
|
Human Thymic Fibroblasts (8G3) |
200 мкг/мл | |
sc-53893 |
|
Hu-TNFα/CD69/CD4 |
50 tests | |
sc-3610 |
|
Hu-TNFα/CD69/CD4 control |
50 tests | |
sc-3610 CON |
|
ICOS (151-9) |
200 мкг/мл | |
sc-53020 |
|
ICOS (151-9) FITC |
100 tests in 2 ml | |
sc-53020 FITC |
|
ICOS (151-9) PE |
100 tests in 2ml | |
sc-53020 PE |
|
ICOS (15F9) |
200 мкг/мл | |
sc-53698 |
|
ICOS (27A12) |
200 мкг/мл | |
sc-53028 |
|
ICOS (27A12) FITC |
100 tests in 2 ml | |
sc-53028 FITC |
|
ICOS (27A12) PE |
100 tests in 2ml | |
sc-53028 PE |
|
ICOS (ANC6C6-A3) |
100 µg/ml | |
sc-65285 |
|
ICOS (C-20) |
200 мкг/мл | |
sc-9554 |
|
ICOS (C-20) P |
100 µg/0.5 ml | |
sc-9554 P |
|
ICOS (FL-199) |
200 мкг/мл | |
sc-25585 |
|
ICOS (h)-PR |
10 µM, 20 µl | |
sc-42770-PR |
|
ICOS (L-16) |
200 мкг/мл | |
sc-5745 |
|
ICOS (L-16) P |
100 µg/0.5 ml | |
sc-5745 P |
|
ICOS (m)-PR |
10 µM, 20 µl | |
sc-42771-PR |
|
ICOS (M-15) |
200 мкг/мл | |
sc-5748 |
|
ICOS (M-15) P |
100 µg/0.5 ml | |
sc-5748 P |
|
ICOS (W-18) |
200 мкг/мл | |
sc-9553 |
|
ICOS (W-18) P |
100 µg/0.5 ml | |
sc-9553 P |
|
ICOS siRNA (h) |
10 µM | |
sc-42770 |
|
ICOS siRNA (m) |
10 µM | |
sc-42771 |
|
ICOS-L (GM-13C1) |
200 мкг/мл | |
sc-59263 |
|
IFITM1 (P-17) |
200 мкг/мл | |
sc-34171 |
|
IFITM1 (P-17) P |
100 µg/0.5 ml | |
sc-34171 P |
|
Ig J Chain (h)-PR |
10 µM, 20 µl | |
sc-45773-PR |
|
Ig J Chain (m)-PR |
10 µM, 20 µl | |
sc-45774-PR |
|
Ig J chain (P-18) |
200 мкг/мл | |
sc-34652 |
|
Ig J chain (P-18) P |
100 µg/0.5 ml | |
sc-34652 P |
|
Ig J chain (S-16) |
200 мкг/мл | |
sc-34654 |
|
Ig J chain (S-16) P |
100 µg/0.5 ml | |
sc-34654 P |
|
Ig J Chain siRNA (h) |
10 µM | |
sc-45773 |
|
Ig J Chain siRNA (m) |
10 µM | |
sc-45774 |
|
Ig κ (m)-PR |
10 µM, 20 µl | |
sc-42888-PR |
|
Ig κ Chain (4C11) |
100 мкг/мл | |
sc-51981 |
|
Ig κ Chain (4G7) (иммуноглобулин) |
100 мкг/мл | |
sc-51982 |
|
Ig κ chain (H-225) |
200 мкг/мл | |
sc-33132 |
|
Ig κ chain (KP-53) |
500 µl ascites | |
sc-59264 |
|
Ig κ chain (L1C1) |
200 мкг/мл | |
sc-59265 |
|
Ig κ chain (M-13) |
200 мкг/мл | |
sc-22104 |
|
Ig κ chain (M-13) P |
100 µg/0.5 ml | |
sc-22104 P |
|
Ig κ chain (M-130) |
200 мкг/мл | |
sc-33133 |
|
Ig κ chain (MEM-09) |
100 µg/ml | |
sc-51637 |
|
Ig κ chain (MH19-1) |
500 мкл | |
sc-52338 |
|
Ig κ Chain (MRK-81) |
100 мкг/мл | |
sc-53702 |
|
Ig κ chain (OX11) |
200 мкг/мл | |
sc-53078 |
|
Ig κ chain (OX11) FITC |
100 tests in 2 ml | |
sc-53078 FITC |
|
Ig κ chain (OX11) PE |
100 tests in 2ml | |
sc-53078 PE |
|
Ig κ chain (OX12) |
200 мкг/мл | |
sc-53079 |
|
Ig κ chain (OX12) FITC |
100 tests in 2 ml | |
sc-53079 FITC |
|
Ig κ chain (OX12) PE |
100 tests in 2ml | |
sc-53079 PE |
|
Ig κ chain (OX20) |
200 мкг/мл | |
sc-53080 |
|
Ig κ chain (OX20) FITC |
100 tests in 2 ml | |
sc-53080 FITC |
|
Ig κ chain (OX20) PE |
100 tests in 2ml | |
sc-53080 PE |
|
Ig κ Chain (RMK-12) |
100 мкг/мл | |
sc-53703 |
|
Ig κ siRNA (m) |
10 µM | |
sc-42888 |
|
Ig λ (h)-PR |
10 µM, 20 µl | |
sc-42889-PR |
|
Ig λ (m)-PR |
10 µM, 20 µl | |
sc-42890-PR |
|
Ig λ Chain (2G9) (иммуноглобулин) |
100 мкг/мл | |
sc-51979 |
|
Ig λ Chain (3D12) |
100 мкг/мл | |
sc-51980 |
|
Ig λ chain (48) |
500 µl supernatant | |
sc-52339 |
|
Ig λ chain (H-110) |
200 мкг/мл | |
sc-33134 |
|
Ig λ chain (K-20) |
200 мкг/мл | |
sc-22108 |
|
Ig λ chain (K-20) P |
100 µg/0.5 ml | |
sc-22108 P |
|
Ig λ chain (M-110) |
200 мкг/мл | |
sc-33135 |
|
Ig λ chain (MHL-38) |
100 µg/ml | |
sc-53701 |
|
Ig λ chain (N10/2) |
200 мкг/мл | |
sc-53344 |
|
Ig λ chain (N-15) |
200 мкг/мл | |
sc-22107 |
|
Ig λ chain (N-15) P |
100 µg/0.5 ml | |
sc-22107 P |
|
Ig λ chain (Rs4) |
100 µg/ml | |
sc-51638 |
|
Ig λ chain (T-17) |
200 мкг/мл | |
sc-22105 |
|
Ig λ chain (T-17) P |
100 µg/0.5 ml | |
sc-22105 P |
|
Ig λ light chain (C4) |
100 мкг/мл | |
sc-59266 |
|
Ig λ light chain (ICO106) |
200 мкг/мл | |
sc-59267 |
|
Ig λ light chain (MRL-61) |
100 мкг/мл | |
sc-53704 |
|
Ig λ siRNA (h) |
10 µM | |
sc-42889 |
|
Ig λ siRNA (m) |
10 µM | |
sc-42890 |
|
IgA (C-16) |
200 мкг/мл | |
sc-34788 |
|
IgA (C-16) P |
100 µg/0.5 ml | |
sc-34788 P |
|